Alpha Cognition Debt to Equity Ratio 2020-2024 | ACOG
Current and historical debt to equity ratio values for Alpha Cognition (ACOG) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Alpha Cognition debt/equity for the three months ending June 30, 2024 was 0.00.
| Alpha Cognition Debt/Equity Ratio Historical Data |
| Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
| 2024-06-30 |
$0.00B |
$-0.00B |
-2.49 |
| 2024-03-31 |
$0.00B |
$0.00B |
18.30 |
| 2023-12-31 |
$0.01B |
$-0.01B |
-1.52 |
| 2023-09-30 |
$0.01B |
$-0.01B |
-1.28 |
| 2023-06-30 |
$0.00B |
$0.00B |
-5.07 |
| 2023-03-31 |
$0.00B |
$0.00B |
2.51 |
| 2022-12-31 |
$0.00B |
$-0.00B |
-3.24 |
| 2022-09-30 |
$0.00B |
$0.00B |
1.52 |
| 2022-06-30 |
$0.00B |
$0.00B |
0.64 |
| 2022-03-31 |
$0.00B |
$0.01B |
0.56 |
| 2021-12-31 |
$0.00B |
$0.01B |
0.43 |
| 2021-09-30 |
$0.01B |
$0.00B |
3.48 |
| 2021-06-30 |
$0.01B |
$-0.00B |
-7.10 |
| 2021-03-31 |
$0.01B |
$-0.00B |
-7.34 |
| 2020-12-31 |
$0.01B |
$0.00B |
526.26 |
| 2020-09-30 |
$0.00B |
$0.00B |
0.00 |
| 2020-06-30 |
$0.00B |
$0.00B |
0.00 |
| 2020-03-31 |
$0.00B |
$0.00B |
0.00 |
| 2019-12-31 |
$0.00B |
$0.01B |
0.22 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-BIOMED/GENE |
$0.035B |
$0.000B |
|
Alpha Cognition Inc. is a clinical stage biopharmaceutical company. It involved in developing treatments for under-served neurodegenerative diseases, such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. Alpha Cognition Inc. is based in Vancouver, British Columbia.
|
